Piekos Brian
CIK: 0001815308•Chief Financial Officer
Officer
Primary company: KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian is a corporate insider (Chief Financial Officer) at KalVista Pharmaceuticals, Inc. (KALV) filing SEC Form 4 transactions. 20 transactions across 4 companies, totaling $72,432 in purchases and $60,139 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 1,489 | $26.78 | $40K | 21,661 | 5/22/2026 Filed: 5/21/2026 | Filing → | |
| Exercise | 5,000 | - | - | 55,000 | 5/21/2026 Filed: 5/21/2026 | Filing → | |
| Exercise | 5,000 | - | - | 23,150 | 5/21/2026 Filed: 5/21/2026 | Filing → | |
| Sale | 1,862 | $20.22 | $38K | 18,150 | 4/17/2026 Filed: 4/20/2026 | Filing → | |
| Exercise | 6,250 | - | - | 93,750 | 4/16/2026 Filed: 4/20/2026 | Filing → | |
| Exercise | 6,250 | - | - | 20,012 | 4/16/2026 Filed: 4/20/2026 | Filing → | |
| Sale | 4,471 | $13.45 | $60K | 10,529 | 11/24/2025 Filed: 11/26/2025 | Filing → | |
| Exercise | 15,000 | - | - | 65,000 | 11/21/2025 Filed: 11/26/2025 | Filing → | |
| Exercise | 15,000 | - | - | 15,000 | 11/21/2025 Filed: 11/26/2025 | Filing → | |
| Award | 80,000 | - | - | 80,000 | 2/21/2025 Filed: 2/25/2025 | Filing → | |
| Award | 100,000 | - | - | 100,000 | 9/9/2024 Filed: 9/11/2024 | Filing → | |
| Award | 43,225 | - | - | 43,225 | 2/1/2024 Filed: 2/5/2024 | Filing → | |
| Award | 75,484 | $0.00 | $0 | 75,484 | 6/1/2023 Filed: 6/5/2023 | Filing → | |
Gemini Therapeutics, Inc. /DE GMTX | Award | 9,960 | $1.09 | $11K | 17,615 | 5/31/2022 Filed: 6/2/2022 | Filing → |
Gemini Therapeutics, Inc. /DE GMTX | Award | 280,876 | $0.00 | $0 | 280,876 | 1/13/2022 Filed: 1/14/2022 | Filing → |
Gemini Therapeutics, Inc. /DE GMTX | Award | 90,720 | $0.00 | $0 | 90,720 | 10/18/2021 Filed: 10/20/2021 | Filing → |
Gemini Therapeutics, Inc. /DE GMTX | Purchase | 7,655 | $9.46 | $72K | 7,655 | 5/14/2021 Filed: 5/18/2021 | Filing → |
Gemini Therapeutics, Inc. /DE GMTX | Award | 377,734 | $0.00 | $0 | 377,734 | 4/12/2021 Filed: 4/14/2021 | Filing → |
| Disposition | 9,500 | - | - | 0 | 11/16/2020 Filed: 11/17/2020 | Filing → | |
| Disposition | 31,538 | - | - | 0 | 11/16/2020 Filed: 11/17/2020 | Filing → |
Type
Sale
Shares
1,489
Price
$26.78
Value
$40K
Type
Exercise
Shares
5,000
Price
-
Value
-
Type
Exercise
Shares
5,000
Price
-
Value
-
Type
Sale
Shares
1,862
Price
$20.22
Value
$38K
Type
Exercise
Shares
6,250
Price
-
Value
-
Type
Exercise
Shares
6,250
Price
-
Value
-
Type
Sale
Shares
4,471
Price
$13.45
Value
$60K
Type
Exercise
Shares
15,000
Price
-
Value
-
Type
Exercise
Shares
15,000
Price
-
Value
-
Type
Award
Shares
80,000
Price
-
Value
-
Type
Award
Shares
100,000
Price
-
Value
-
Type
Award
Shares
43,225
Price
-
Value
-
Type
Award
Shares
75,484
Price
$0.00
Value
$0
Gemini Therapeutics, Inc. /DE
GMTX
Type
Award
Shares
9,960
Price
$1.09
Value
$11K
Gemini Therapeutics, Inc. /DE
GMTX
Type
Award
Shares
280,876
Price
$0.00
Value
$0
Gemini Therapeutics, Inc. /DE
GMTX
Type
Award
Shares
90,720
Price
$0.00
Value
$0
Gemini Therapeutics, Inc. /DE
GMTX
Type
Purchase
Shares
7,655
Price
$9.46
Value
$72K
Gemini Therapeutics, Inc. /DE
GMTX
Type
Award
Shares
377,734
Price
$0.00
Value
$0
Type
Disposition
Shares
9,500
Price
-
Value
-
Type
Disposition
Shares
31,538
Price
-
Value
-
AI Agent
Try asking...